Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme

This is a preview of subscription content, access via your institution.

Notes

  1. 1.

    On the other hand, the MTEP guidance may be more acceptable in certain non-UK countries, such as France and Germany, where there is no attempt to measure health benefits in a standardised way. However, these countries do place a great emphasis on the need for evidence from RCTs and are reluctant to base decisions on the reimbursement of new technologies on alternative data sources, as the MTEP does.

References

  1. 1.

    Raftery, J.: Review of NICE’s recommendations, 1995–2005. BMJ 332, 1266–1268 (2006)

    PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Drummond, M., Schwartz, J., Jonsson, B., Luce, B., Neumann, P., Siebert, U., Sullivan, S.: Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int. J. Technol. Assess. Health Care 24(3), 244–258 (2008)

    PubMed  Google Scholar 

  3. 3.

    NICE: A guide to NICE. NICE, London (2005)

    Google Scholar 

  4. 4.

    Sorenson, C., Tarricone, R., Siebert, U., Drummond, M.: Applying health economics for policy decision making: do devices differ from drugs? Europace 13, 54–58 (2011)

    Article  Google Scholar 

  5. 5.

    NICE: Medical technologies evaluation programme—methods guide. http://www.nice.org.uk/media/3A6/09/MedicalTechnologiesEvaluationProgrammeMethodsGuideMarch2012.pdf (2011). Accessed 21 Oct 2012

  6. 6.

    Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., Stoddart, G.: Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, Oxford (2005)

    Google Scholar 

  7. 7.

    NICE: Medical technologies evaluation programme—process guide. http://www.nice.org.uk/media/3A6/14/MedicalTechnologiesEvaluationProgrammeProcessGuideMarch2012.pdf (2011). Accessed 21 Oct 2012

  8. 8.

    Cookson, R., Hutton, J.: Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective. Health Policy 63, 167–178 (2003)

    PubMed  Article  Google Scholar 

  9. 9.

    Taylor, R., Iglesias, C.: Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? Value Health 12(4), 404–406 (2009)

    PubMed  Article  Google Scholar 

  10. 10.

    NICE: Technology appraisals topic selection. http://www.nice.org.uk/getinvolved/topicselection/TechnologyAppraisalTopicSelection.jsp(2011). Accessed 24 June 2011

  11. 11.

    NICE: Guide to the methods of technology appraisal. http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9 (2013). Accessed 4 April 2013

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to William Green.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Green, W., Hutton, J. Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme. Eur J Health Econ 15, 449–452 (2014). https://doi.org/10.1007/s10198-013-0539-3

Download citation